Kubo T - Search Results

1

Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors.

Honda Y, Takigawa N, Fushimi S, Ochi N, Kubo T, Ozaki S, Tanimoto M, Kiura K. Honda Y, et al. Among authors: kubo t. Lung Cancer. 2012 Oct;78(1):121-4. doi: 10.1016/j.lungcan.2012.07.003. Epub 2012 Jul 25. Lung Cancer. 2012. PMID: 22835516

2

[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].

Kubo T, Takigawa N, Tanimoto Y, Ichihara E, Tabata M, Miyahara N, Kanehiro A, Kiura K, Tanimoto M. Kubo T, et al. Nihon Kokyuki Gakkai Zasshi. 2007 Oct;45(10):808-11. Nihon Kokyuki Gakkai Zasshi. 2007. PMID: 18018632 Japanese.

3

Efficacy of a lumbo-peritoneal shunt for meningeal carcinomatosis refractory to gefitinib treatment.

Kubo T, Takigawa N, Kiura K, Nishida A, Ochi N, Kashihara H, Umemura S, Hisamoto A, Tanimoto M. Kubo T, et al. Anticancer Res. 2009 Jul;29(7):2759-60. Anticancer Res. 2009. PMID: 19596957 Free article.

4

Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice.

Ohashi K, Takigawa N, Osawa M, Ichihara E, Takeda H, Kubo T, Hirano S, Yoshino T, Takata M, Tanimoto M, Kiura K. Ohashi K, et al. Among authors: kubo t. Cancer Res. 2009 Sep 1;69(17):7088-95. doi: 10.1158/0008-5472.CAN-08-4205. Epub 2009 Aug 18. Cancer Res. 2009. PMID: 19690148

5

STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.

Takata S, Takigawa N, Segawa Y, Kubo T, Ohashi K, Kozuki T, Teramoto N, Yamashita M, Toyooka S, Tanimoto M, Kiura K. Takata S, et al. Among authors: kubo t. Lung Cancer. 2012 Jan;75(1):24-9. doi: 10.1016/j.lungcan.2011.05.015. Lung Cancer. 2012. PMID: 21684622

6

Harada D, Takigawa N, Ochi N, Ninomiya T, Yasugi M, Kubo T, Takeda H, Ichihara E, Ohashi K, Takata S, Tanimoto M, Kiura K. Harada D, et al. Among authors: kubo t. Cancer Sci. 2012 Oct;103(10):1795-802. doi: 10.1111/j.1349-7006.2012.02363.x. Epub 2012 Jul 24. Cancer Sci. 2012. PMID: 22712764 Free PMC article.

7

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.

Kubo T, Takigawa N, Osawa M, Harada D, Ninomiya T, Ochi N, Ichihara E, Yamane H, Tanimoto M, Kiura K. Kubo T, et al. Cancer Sci. 2013 Jan;104(1):78-84. doi: 10.1111/cas.12045. Epub 2012 Nov 24. Cancer Sci. 2013. PMID: 23066953 Free PMC article.

8

Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model.

Ninomiya T, Takigawa N, Ichihara E, Ochi N, Murakami T, Honda Y, Kubo T, Minami D, Kudo K, Tanimoto M, Kiura K. Ninomiya T, et al. Among authors: kubo t. Mol Cancer Ther. 2013 May;12(5):589-97. doi: 10.1158/1535-7163.MCT-12-0885. Epub 2013 Feb 26. Mol Cancer Ther. 2013. PMID: 23443806 Free article.

9

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model.

Murakami T, Takigawa N, Ninomiya T, Ochi N, Yasugi M, Honda Y, Kubo T, Ichihara E, Hotta K, Tanimoto M, Kiura K. Murakami T, et al. Among authors: kubo t. Lung Cancer. 2014 Jan;83(1):30-6. doi: 10.1016/j.lungcan.2013.10.011. Epub 2013 Oct 29. Lung Cancer. 2014. PMID: 24238495 Free article.

10

Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report.

Morichika D, Sato-Hisamoto A, Hotta K, Takata K, Iwaki N, Uchida K, Minami D, Kubo T, Tanimoto M, Kiura K. Morichika D, et al. Among authors: kubo t. Jpn J Clin Oncol. 2014 May;44(5):501-5. doi: 10.1093/jjco/hyu019. Epub 2014 Mar 19. Jpn J Clin Oncol. 2014. PMID: 24646812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,385 results

Search Page

Filters